ELAIA-2
Elaia-2 is a randomized, controlled trial of drug-targeted alerts for Acute Kidney Injury
Click the link below to read the full protocol for ELAIA-2:
ELAIA-1
ELAIA-1 is a randomized, controlled trial of informational alerts for Acute Kidney Injury
Click the link below to read the full protocol for ELAIA-1:
Electronic Alerting for Acute Kidney Injury Amelioration - Protocol Version 1.7
Below is a brief video describing the ELAIA-1 trial and the AKI alert interface:
What the alert looks like:
This is an example of an alert that will pop up in the electronic medical record of a patient who has been randomized to the alert arm of the trial. If the alert is dismissed, it will continue to pop up each time the patient's chart is opened. Once a provider either "agrees" or "disagrees" with the alert, the "Accept" button will become highlighted. Accepting the alert will suppress the alert for 48 hours (only for the provider who accepted the alert).